In 2015, a new group of drugs was introduced that could have a great impact on the aging process and slow it down. By improving the potency and safety of these senolytic drugs, scientists have been able to discover that they are a pioneer in the treatment of antibodies, attacking target cells with greater precision and not harming healthy cells.
The potential of senolytic drugs lies in their ability to target senescent cells. These cells are no longer able to divide and produce new cells, and they accumulate in the body, increasing the rate of aging. This is a natural process, but scientists have been able to take different ways to get rid of these cells.
Experiments have shown that senolytic drugs can rejuvenate old rodent cells and increase their lifespan. In addition, recent advances in these drugs have been able to extend human health. In a recent experiment, researchers showed that these drugs were able to kill old rodent cells in the spine and create enough space for healthy cells to grow. Such a thing would probably be a cure for chronic low back pain.
However, the synolytic drugs that have been developed so far are completely unofficial and can have devastating side effects. For this reason, researchers are more interested in the latter and the latter class of drugs because they kill aging cells without damaging other cells.
The second group of senolytic drugs was developed based on research that found a specific protein on the membrane of aging cells and showed that by targeting this protein, these cells can be targeted and killed with high accuracy.
These drugs work like smart bombs in the body and kill aging cells by detecting them and injecting them with toxic drugs. This idea was previously used in the treatment of cancer and is now used to prevent aging. Scientists hope to use these drugs in humans to treat some age-related diseases.
0 Comments:
Post a Comment
Your comment and facebook share will be appreciated